Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors – MedCity News
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Using only a typical mammogram image, the system is able to pinpoint women at a high risk of developing breast…